Investigating synergism of Mcl-1 inhibition with first line therapies for leukaemia

被引：0
|
作者：
Cosimo, E. [1 ]
Ball, R. J. [1 ]
Couves, A. [1 ]
Allan, E. K. [1 ]
Jorgensen, H. G. [1 ]
Michie, A. M. [1 ]
机构：
[1] Univ Glasgow, Inst Canc Sci, Paul OGorman Leukaemia Res Ctr, Glasgow, Lanark, Scotland
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2012年 / 157卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
148
引用
收藏
页码：57 / 58
页数：2
相关论文
共 50 条
  • [41] Inhibition of MCL-1 in breast cancer cells promotes cell death in vitro and in vivo
    Mitchell, Clint
    Yacoub, Adly
    Hamed, Hossein
    Martin, Aditi Pandya
    Bareford, M. Danielle
    Eulitt, Patrick
    Yang, Chen
    Nephew, Kenneth P.
    Dent, Paul
    CANCER BIOLOGY & THERAPY, 2010, 10 (09) : 907 - 921
  • [42] NEW THERAPEUTICAL APPROACH FOR HEPATOCELLULAR CARCINOMA: INHIBITION OF BCL-2 AND MCL-1
    Walz, Franziska
    Michalski, Marlen
    Bauer, Magdalena
    Mueller-Schilling, Martina
    Guelow, Karsten
    HEPATOLOGY, 2022, 76 : S1255 - S1255
  • [43] Dual inhibition of Mcl-1 by the combination of carfilzomib and TG02 in multiple myeloma
    Ponder, Katelyn G.
    Matulis, Shannon M.
    Hitosugi, Sadae
    Gupta, Vikas A.
    Sharp, Cathy
    Burrows, Francis
    Nooka, Ajay K.
    Kaufman, Jonathan L.
    Lonial, Sagar
    Boise, Lawrence H.
    CANCER BIOLOGY & THERAPY, 2016, 17 (07) : 769 - 777
  • [44] Dual Inhibition Of Mcl-1 By The Combination Of Carfilzomib and TG02 In Multiple Myeloma
    Barnhart, Katelyn G.
    Matulis, Shannon M.
    Hitosugi, Sadae
    Sharp, Cathy
    Burrows, Francis
    Nooka, Ajay K.
    Kaufman, Jonathan L.
    Lonial, Sagar
    Boise, Lawrence H.
    BLOOD, 2013, 122 (21)
  • [45] Comparison of Umbelliprenin and Auraptene in Cytotoxic Effects and Myeloid Cell Leukaemia Type-1 (Mcl-1) Gene Expression
    Motlagh, F. Movahedi
    Gholami, O.
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2016, 78 (06) : 827 - 833
  • [46] Fibroblast Growth Factor Receptor (FGFR) Inhibition in Cholangiocarcinoma (CCA) Cells Causes Loss of Mcl-1 Resulting in Necrosis but Not Apoptosis: A New Paradigm for Mcl-1 Survival Function
    Niibe, Ayano
    Bronk, Steven
    Hirsova, Petra
    Werneburg, Nathan
    Gores, Gregory J.
    HEPATOLOGY, 2016, 64 : 240A - 240A
  • [47] Zoledronic acid increases docetaxel cytotoxicity through pMEK and Mcl-1 inhibition in a hormone-sensitive prostate carcinoma cell line
    Francesco Fabbri
    Giovanni Brigliadori
    Silvia Carloni
    Paola Ulivi
    Ivan Vannini
    Anna Tesei
    Rosella Silvestrini
    Dino Amadori
    Wainer Zoli
    Journal of Translational Medicine, 6
  • [48] Potent efficacy of MCL-1 inhibitor-based therapies in preclinical models of mantle cell lymphoma
    Michael A. Dengler
    Charis E. Teh
    Rachel Thijssen
    Lahiru Gangoda
    Ping Lan
    Marco J. Herold
    Daniel H. Gray
    Gemma L. Kelly
    Andrew W. Roberts
    Jerry M. Adams
    Oncogene, 2020, 39 : 2009 - 2023
  • [49] Mcl-1 promoter insertions as an independent prognostic factor for treatment free survival in chronic lymphocytic leukaemia.
    Hooper, Laura
    Delgado, Julio
    Starczynski, Jane
    Evans, Jason
    Pepper, Chris
    Greenwell, Pamela
    Fegan, Chris
    Pratt, Guy
    BLOOD, 2006, 108 (11) : 319B - 319B
  • [50] Arsenic trioxide synergistically promotes the antileukaemic activity of venetoclax by downregulating Mcl-1 in acute myeloid leukaemia cells
    Hyunsoo Cho
    Ji Eun Jang
    Ju-In Eom
    Hoi-Kyung Jeung
    Haerim Chung
    Jin Seok Kim
    June-Won Cheong
    Yoo Hong Min
    Experimental Hematology & Oncology, 10
12345